Index Entries

Parawee Chevaisrakul, Putthapoom Lumjiaktase, Pongtorn Kietdumrongwong, Ittiporn Chuatrisorn, Pongsan Chatsangjaroen, and Nittaya Phanuphak
January 14, 2023
Nature Scientific Reports
Mahidol University (Thailand)

Abstract: … Hybrid immunity provided by a combination of vaccination and infection, including asymptomatic infection, may confer effective protection against death. We explored the combined effect of asymptomatic infection and hybrid immunity by studying T-cell and antibody responses against SARS-CoV-2 among individuals treated in home health care services 6 months after SARS-CoV-2 exposure. Asymptomatic SARS-CoV-2 infection was demonstrated in 24.4% of close contacts. The levels of immunity were not different between patients and close contacts. Anti-RBD IgG against SARS-CoV-2 increased in a dose-dependent manner with the number of vaccine doses. Interestingly, the T-cell response decreased soon after a booster dose of vaccine. Asymptomatic SARS-CoV-2 infection could not enhance immunity against SARS-CoV-2 among vaccinated close contacts. Full vaccination was crucial to provide hybrid immunity. However, when designing vaccine strategies, T-cell exhaustion after multiple vaccinations should be considered…

Results: … After vaccination, increments of RBD IgG levels were observed in a dose-dependent manner according to the number of vaccine doses among both patients and close contacts. However, the T-cell response did not increase in the same pattern as RBD IgG. There was a significant decrease in T-cell responses against the S antigen in participants who received three and four doses of the vaccine.”

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http:// creativecommons. org/ licenses/ by/4. 0/.

document
adverse events,COVID-19,immunodeficiency and immunopathological disorders,natural immunity,vaccines